0
Errata |

Correction to Online Text: Executive Summary: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines FREE TO VIEW

Chest. 2012;142(6):1698. doi:10.1378/chest.12-2126
Text Size: A A A
Published online

The article “Executive Summary: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines” published in the February 2012 supplement of CHEST (2012;141[2][Suppl]:7S-47S) contained an error in the online text. The error was on page 31S on recommendation 2.0.2.

The corrected text reads:

2.0.2. In patients with rheumatic mitral valve disease and normal sinus rhythm with a left atrial diameter >55 mm, we suggest VKA therapy (target INR, 2.5; range, 2.0-3.0) over no VKA therapy or antiplatelet (Grade 2C).

This error occurred only in the online version of the text; the PDF and print version are correct. The text has been corrected online.


Figures

Tables

References

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.

  • CHEST Journal
    Print ISSN: 0012-3692
    Online ISSN: 1931-3543